Is small intestine evaluation necessary for a patient with a history of melena (black, tarry stools), 4 years prior, and normal colonoscopy and esophagogastroduodenoscopy (EGD), with no recurrence since then?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Given your history of melena with normal colonoscopy and endoscopy, and considering the latest guidelines, consulting a gastroenterologist about evaluating the small intestine is a reasonable next step, with capsule endoscopy being a recommended diagnostic tool for patients with overt, obscure GI bleeding and negative findings on high-quality EGD and colonoscopy, as stated in Statement 8 by 1. The small intestine is a potential source of bleeding that was not examined in your previous tests. Several factors will influence the decision to proceed with testing, including the severity of your original bleeding episode, current health status, age, family history, and any ongoing symptoms like anemia. Although you haven't had a recurrence in four years, which is reassuring, identifying the source of unexplained GI bleeding is ideal for preventing future complications. Small intestinal causes of bleeding can include small bowel tumors, Crohn's disease, angiodysplasias, or Meckel's diverticulum, among others. Capsule endoscopy is typically the first-line test for evaluating the small bowel, with other options including balloon-assisted enteroscopy or CT/MR enterography, as supported by the clinical practice guidelines for the use of video capsule endoscopy 1. It's also worth noting that recent guidelines, such as those from 2025, focus on the management of specific conditions like nonampullary duodenal lesions but do not directly address the necessity of small bowel investigation in patients with a history of melena and normal upper and lower endoscopy, making the 2017 guidelines on capsule endoscopy more relevant to your situation 1. However, the key consideration in your case remains the identification of the source of past bleeding and the prevention of future episodes, which aligns with the recommendation for capsule endoscopy in patients with overt, obscure GI bleeding, as per 1.

From the Research

Recurrence of Melena and Need for Small Intestine Check

  • The patient had melena 4 years ago, but colonoscopy and endoscopy were normal, and there has been no recurrence since then.
  • According to the study 2, obscure gastrointestinal bleeding is recurrent bleeding when the source remains unidentified after upper endoscopy and colonoscopic evaluation and is usually from the small intestine.
  • The study 3 suggests that the presence of melena predicts bleeding in the proximal small intestine in patients with obscure gastrointestinal bleeding.
  • However, the study 4 found that the diagnostic yield of colonoscopy to investigate melena after nondiagnostic EGD is low, and the need for therapeutic intervention during colonoscopy for this indication is very low.
  • The study 5 found that further evaluation after nondiagnostic upper endoscopy reveals a potential source in 37% of patients with melena, with the right colon being the most likely location of pathology.

Evaluation of Patients with Melena

  • The study 6 suggests that same-day upper and lower endoscopy can be useful in patients investigated for non-acute gastrointestinal bleeding, as a potential bleeding source could be missed if only one of these procedures is performed.
  • The study 5 found that colonoscopy is the test of choice in patients with melena and nondiagnostic upper endoscopy.
  • The study 3 recommends that deep enteroscopy, if performed before a capsule study, should begin with an antegrade approach in patients with melena and obscure gastrointestinal bleeding.

Need to Check the Small Intestine

  • Based on the studies 2 and 3, it can be inferred that if the patient had melena and normal colonoscopy and endoscopy, and there is a recurrence, it may be necessary to check the small intestine to rule out obscure gastrointestinal bleeding.
  • However, the decision to check the small intestine should be based on the individual patient's clinical presentation and medical history, as suggested by the study 4.

Related Questions

What is the significance of a past episode of melena (black, tarry stools), which occurred 4 years ago, with subsequent normal colonoscopy (examination of the colon) and endoscopy (examination of the upper gastrointestinal tract), and no recurrence of melena since?
What are the diagnostic steps for melena?
Is small intestine evaluation necessary in a patient with a history of melena (black, tarry stools), 4 years prior, and normal colonoscopy, esophagogastroduodenoscopy (endoscopy), and abdominal computed tomography (CT) scan with contrast, without recurrence?
What is the gastric transit time in patients with melena?
What are the investigations for melena (black tarry stools)?
What is Sulindac (a nonsteroidal anti-inflammatory drug, NSAID)?
Is there a need to examine the small intestine?
What is the significance of having melena (black, tarry stools) 4 years ago with normal test results?
Is small intestine evaluation necessary in a patient with a history of melena (black, tarry stools), 4 years prior, and normal colonoscopy, esophagogastroduodenoscopy (endoscopy), and abdominal computed tomography (CT) scan with contrast, without recurrence?
What are the risks of complications or factors that can impact birth or a new pregnancy in a couple where the husband is HIV (Human Immunodeficiency Virus) negative, taking PrEP (Pre-Exposure Prophylaxis), and has a history of HSV-2 (Herpes Simplex Virus Type 2) in remission, and the 27-year-old wife has a history of substance use disorder, now in recovery?
Can mirtazapine (Remeron) be discontinued without a taper?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.